Tech Company Financing Transactions

NewLeaf Symbiotics Funding Round

On 12/19/2023, NewLeaf Symbiotics raised $45 million in Series D funding from Gullspang Refood, Leaps by Bayer and Otter Capital.

Transaction Overview

Company Name
Announced On
12/19/2023
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series D
Proceeds Purpose
With this funding, NewLeaf will accelerate its efforts with PPFM technology and adjacent technologies in the areas of biostimulants/microbial inoculants, biocontrol, nitrogen use efficiency and methane mitigation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1005 North Warson Rd.
St. Louis, MO 63132
USA
Email Address
Overview
NewLeaf Symbiotics is a science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria.
Profile
NewLeaf Symbiotics LinkedIn Company Profile
Social Media
NewLeaf Symbiotics Company Twitter Account
Company News
NewLeaf Symbiotics News
Facebook
NewLeaf Symbiotics on Facebook
YouTube
NewLeaf Symbiotics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Kahn
  Stephen Kahn LinkedIn Profile  Stephen Kahn Twitter Account  Stephen Kahn News  Stephen Kahn on Facebook
Chief Scientific Officer
Desmond Jimenez
  Desmond Jimenez LinkedIn Profile  Desmond Jimenez Twitter Account  Desmond Jimenez News  Desmond Jimenez on Facebook
Chief Technical Officer
Janne Kerovuo
  Janne Kerovuo LinkedIn Profile  Janne Kerovuo Twitter Account  Janne Kerovuo News  Janne Kerovuo on Facebook
VP - Bus. Development
Matthew Helms
  Matthew Helms LinkedIn Profile  Matthew Helms Twitter Account  Matthew Helms News  Matthew Helms on Facebook
VP - General Counsel
Molly Edwards
  Molly Edwards LinkedIn Profile  Molly Edwards Twitter Account  Molly Edwards News  Molly Edwards on Facebook
VP - Manufacturing
Aaron Kelley
  Aaron Kelley LinkedIn Profile  Aaron Kelley Twitter Account  Aaron Kelley News  Aaron Kelley on Facebook
VP - R & D
Natalie Breakfield
  Natalie Breakfield LinkedIn Profile  Natalie Breakfield Twitter Account  Natalie Breakfield News  Natalie Breakfield on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/19/2023: Kimia Therapeutics venture capital transaction
Next: 12/19/2023: GTA venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document tech company VC transactions. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary